Our publications related to cancer biomarkers
DUSP4 is associated with increased resistance against anti-HER2 therapy in breast cancer. Oncotarget. 8(44):77207-77218.
.
2017. DUSP4 is associated with increased resistance against anti-HER2 therapy in breast cancer. Oncotarget. 8(44):77207-77218.
.
2017. DUSP4 is associated with increased resistance against anti-HER2 therapy in breast cancer. Oncotarget. 8(44):77207-77218.
.
2017. miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients. Breast Cancer Res Treat. 160(3):446.
.
2016. .
2015.
A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer.. Breast Cancer Res Treat. 140(2):219-32.
.
2013. .
2009.